nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrimethamine—Lamotrigine—epilepsy syndrome	0.625	1	CrCtD
Pyrimethamine—CYP2D6—epilepsy syndrome	0.0952	1	CbGaD
Pyrimethamine—CYP2C8—Trimethadione—epilepsy syndrome	0.0195	0.0968	CbGbCtD
Pyrimethamine—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0183	0.0911	CbGbCtD
Pyrimethamine—CYP2C9—Trimethadione—epilepsy syndrome	0.0136	0.0675	CbGbCtD
Pyrimethamine—CYP2C8—Carbamazepine—epilepsy syndrome	0.0131	0.0654	CbGbCtD
Pyrimethamine—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0128	0.0635	CbGbCtD
Pyrimethamine—CYP2C8—Primidone—epilepsy syndrome	0.0123	0.0611	CbGbCtD
Pyrimethamine—CYP2C8—Phenytoin—epilepsy syndrome	0.0118	0.0587	CbGbCtD
Pyrimethamine—CYP2C8—Propofol—epilepsy syndrome	0.011	0.0547	CbGbCtD
Pyrimethamine—CYP2C8—Phenobarbital—epilepsy syndrome	0.0105	0.0523	CbGbCtD
Pyrimethamine—CYP2C8—Diazepam—epilepsy syndrome	0.00996	0.0496	CbGbCtD
Pyrimethamine—CYP2C9—Carbamazepine—epilepsy syndrome	0.00917	0.0456	CbGbCtD
Pyrimethamine—CYP2C9—Primidone—epilepsy syndrome	0.00856	0.0426	CbGbCtD
Pyrimethamine—CYP2C9—Phenytoin—epilepsy syndrome	0.00822	0.0409	CbGbCtD
Pyrimethamine—CYP2C8—Valproic Acid—epilepsy syndrome	0.00785	0.0391	CbGbCtD
Pyrimethamine—CYP2C9—Propofol—epilepsy syndrome	0.00767	0.0382	CbGbCtD
Pyrimethamine—CYP2C9—Phenobarbital—epilepsy syndrome	0.00733	0.0365	CbGbCtD
Pyrimethamine—CYP2D6—Propofol—epilepsy syndrome	0.00701	0.0349	CbGbCtD
Pyrimethamine—CYP2C9—Diazepam—epilepsy syndrome	0.00695	0.0346	CbGbCtD
Pyrimethamine—CYP2C9—Valproic Acid—epilepsy syndrome	0.00548	0.0273	CbGbCtD
Pyrimethamine—Anaemia megaloblastic—Amobarbital—epilepsy syndrome	0.00445	0.0773	CcSEcCtD
Pyrimethamine—Anaemia megaloblastic—Primidone—epilepsy syndrome	0.00429	0.0745	CcSEcCtD
Pyrimethamine—Anaemia megaloblastic—Phenobarbital—epilepsy syndrome	0.00334	0.058	CcSEcCtD
Pyrimethamine—Anaemia megaloblastic—Phenytoin—epilepsy syndrome	0.00201	0.0349	CcSEcCtD
Pyrimethamine—Anaemia megaloblastic—Carbamazepine—epilepsy syndrome	0.00192	0.0333	CcSEcCtD
Pyrimethamine—Anaemia megaloblastic—Pregabalin—epilepsy syndrome	0.00133	0.0231	CcSEcCtD
Pyrimethamine—DHFR—Niclosamide—Clonazepam—epilepsy syndrome	0.000988	1	CbGdCrCtD
Pyrimethamine—Lamotrigine—SCN8A—epilepsy syndrome	0.000756	0.225	CrCbGaD
Pyrimethamine—Lamotrigine—SCN9A—epilepsy syndrome	0.000611	0.182	CrCbGaD
Pyrimethamine—Lamotrigine—SCN3A—epilepsy syndrome	0.000585	0.174	CrCbGaD
Pyrimethamine—Lamotrigine—SCN4A—epilepsy syndrome	0.000562	0.167	CrCbGaD
Pyrimethamine—Pancytopenia—Trimethadione—epilepsy syndrome	0.00053	0.0092	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Phenobarbital—epilepsy syndrome	0.000515	0.00894	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Lacosamide—epilepsy syndrome	0.000474	0.00824	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Clobazam—epilepsy syndrome	0.00046	0.008	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Phenobarbital—epilepsy syndrome	0.000437	0.00758	CcSEcCtD
Pyrimethamine—Erythema multiforme—Trimethadione—epilepsy syndrome	0.000422	0.00733	CcSEcCtD
Pyrimethamine—Haematuria—Rufinamide—epilepsy syndrome	0.000412	0.00716	CcSEcCtD
Pyrimethamine—Lamotrigine—SCN1A—epilepsy syndrome	0.00041	0.122	CrCbGaD
Pyrimethamine—Toxic epidermal necrolysis—Acetazolamide—epilepsy syndrome	0.00041	0.00713	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Lacosamide—epilepsy syndrome	0.000402	0.00699	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Clobazam—epilepsy syndrome	0.000391	0.00678	CcSEcCtD
Pyrimethamine—Erythema multiforme—Phenobarbital—epilepsy syndrome	0.000374	0.00649	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Levetiracetam—epilepsy syndrome	0.000368	0.0064	CcSEcCtD
Pyrimethamine—Lamotrigine—SCN2A—epilepsy syndrome	0.000362	0.108	CrCbGaD
Pyrimethamine—Stevens-Johnson syndrome—Acetazolamide—epilepsy syndrome	0.000348	0.00605	CcSEcCtD
Pyrimethamine—Leukopenia—Trimethadione—epilepsy syndrome	0.000348	0.00604	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Vigabatrin—epilepsy syndrome	0.000346	0.00602	CcSEcCtD
Pyrimethamine—Erythema multiforme—Lacosamide—epilepsy syndrome	0.000344	0.00598	CcSEcCtD
Pyrimethamine—Anorexia—Primidone—epilepsy syndrome	0.000344	0.00597	CcSEcCtD
Pyrimethamine—Pancytopenia—Levetiracetam—epilepsy syndrome	0.000336	0.00583	CcSEcCtD
Pyrimethamine—Haematuria—Acetazolamide—epilepsy syndrome	0.000335	0.00582	CcSEcCtD
Pyrimethamine—Erythema multiforme—Clobazam—epilepsy syndrome	0.000334	0.00581	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Felbamate—epilepsy syndrome	0.00033	0.00573	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Zonisamide—epilepsy syndrome	0.000323	0.00561	CcSEcCtD
Pyrimethamine—Decreased appetite—Primidone—epilepsy syndrome	0.000313	0.00544	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Levetiracetam—epilepsy syndrome	0.000312	0.00543	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Trimethadione—epilepsy syndrome	0.00031	0.00539	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Phenytoin—epilepsy syndrome	0.000309	0.00537	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Oxcarbazepine—epilepsy syndrome	0.000308	0.00534	CcSEcCtD
Pyrimethamine—Leukopenia—Rufinamide—epilepsy syndrome	0.000302	0.00525	CcSEcCtD
Pyrimethamine—Anorexia—Trimethadione—epilepsy syndrome	0.000302	0.00525	CcSEcCtD
Pyrimethamine—Pancytopenia—Felbamate—epilepsy syndrome	0.000301	0.00523	CcSEcCtD
Pyrimethamine—Erythema multiforme—Acetazolamide—epilepsy syndrome	0.000298	0.00518	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Carbamazepine—epilepsy syndrome	0.000295	0.00513	CcSEcCtD
Pyrimethamine—Pancytopenia—Zonisamide—epilepsy syndrome	0.000294	0.00512	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Vigabatrin—epilepsy syndrome	0.000294	0.0051	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Lamotrigine—epilepsy syndrome	0.000285	0.00496	CcSEcCtD
Pyrimethamine—Pancytopenia—Phenytoin—epilepsy syndrome	0.000282	0.0049	CcSEcCtD
Pyrimethamine—Pancytopenia—Oxcarbazepine—epilepsy syndrome	0.00028	0.00487	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Felbamate—epilepsy syndrome	0.00028	0.00486	CcSEcCtD
Pyrimethamine—Hypersensitivity—Amobarbital—epilepsy syndrome	0.000276	0.00479	CcSEcCtD
Pyrimethamine—Decreased appetite—Trimethadione—epilepsy syndrome	0.000276	0.00479	CcSEcCtD
Pyrimethamine—Leukopenia—Clobazam—epilepsy syndrome	0.000276	0.00479	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Zonisamide—epilepsy syndrome	0.000274	0.00476	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Rufinamide—epilepsy syndrome	0.00027	0.00469	CcSEcCtD
Pyrimethamine—Haematuria—Felbamate—epilepsy syndrome	0.000269	0.00468	CcSEcCtD
Pyrimethamine—Pancytopenia—Carbamazepine—epilepsy syndrome	0.000269	0.00467	CcSEcCtD
Pyrimethamine—Erythema multiforme—Levetiracetam—epilepsy syndrome	0.000267	0.00465	CcSEcCtD
Pyrimethamine—Haematuria—Zonisamide—epilepsy syndrome	0.000264	0.00458	CcSEcCtD
Pyrimethamine—Anorexia—Rufinamide—epilepsy syndrome	0.000263	0.00456	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Phenytoin—epilepsy syndrome	0.000262	0.00456	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Oxcarbazepine—epilepsy syndrome	0.000261	0.00453	CcSEcCtD
Pyrimethamine—Pancytopenia—Lamotrigine—epilepsy syndrome	0.00026	0.00452	CcSEcCtD
Pyrimethamine—Erythema multiforme—Vigabatrin—epilepsy syndrome	0.000252	0.00437	CcSEcCtD
Pyrimethamine—Haematuria—Oxcarbazepine—epilepsy syndrome	0.000251	0.00436	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Carbamazepine—epilepsy syndrome	0.00025	0.00435	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Clobazam—epilepsy syndrome	0.000246	0.00427	CcSEcCtD
Pyrimethamine—Leukopenia—Acetazolamide—epilepsy syndrome	0.000246	0.00427	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Lamotrigine—epilepsy syndrome	0.000242	0.0042	CcSEcCtD
Pyrimethamine—Haematuria—Carbamazepine—epilepsy syndrome	0.000241	0.00418	CcSEcCtD
Pyrimethamine—Erythema multiforme—Felbamate—epilepsy syndrome	0.00024	0.00416	CcSEcCtD
Pyrimethamine—Decreased appetite—Rufinamide—epilepsy syndrome	0.00024	0.00416	CcSEcCtD
Pyrimethamine—Anorexia—Clobazam—epilepsy syndrome	0.000239	0.00416	CcSEcCtD
Pyrimethamine—Vomiting—Amobarbital—epilepsy syndrome	0.000238	0.00413	CcSEcCtD
Pyrimethamine—Erythema multiforme—Zonisamide—epilepsy syndrome	0.000235	0.00408	CcSEcCtD
Pyrimethamine—Haematuria—Lamotrigine—epilepsy syndrome	0.000233	0.00404	CcSEcCtD
Pyrimethamine—Vomiting—Primidone—epilepsy syndrome	0.000229	0.00398	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Valproic Acid—epilepsy syndrome	0.000227	0.00394	CcSEcCtD
Pyrimethamine—Erythema multiforme—Phenytoin—epilepsy syndrome	0.000225	0.0039	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Acetazolamide—epilepsy syndrome	0.000224	0.00389	CcSEcCtD
Pyrimethamine—Erythema multiforme—Oxcarbazepine—epilepsy syndrome	0.000223	0.00388	CcSEcCtD
Pyrimethamine—Leukopenia—Levetiracetam—epilepsy syndrome	0.00022	0.00383	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Acetazolamide—epilepsy syndrome	0.000219	0.00381	CcSEcCtD
Pyrimethamine—Decreased appetite—Clobazam—epilepsy syndrome	0.000218	0.00379	CcSEcCtD
Pyrimethamine—Erythema multiforme—Carbamazepine—epilepsy syndrome	0.000214	0.00372	CcSEcCtD
Pyrimethamine—Leukopenia—Fosphenytoin—epilepsy syndrome	0.000213	0.0037	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Propofol—epilepsy syndrome	0.000208	0.00361	CcSEcCtD
Pyrimethamine—Erythema multiforme—Lamotrigine—epilepsy syndrome	0.000207	0.0036	CcSEcCtD
Pyrimethamine—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.000207	0.00359	CcSEcCtD
Pyrimethamine—Pancytopenia—Valproic Acid—epilepsy syndrome	0.000207	0.00359	CcSEcCtD
Pyrimethamine—Leukopenia—Diazepam—epilepsy syndrome	0.000204	0.00355	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Midazolam—epilepsy syndrome	0.000203	0.00353	CcSEcCtD
Pyrimethamine—Hypersensitivity—Rufinamide—epilepsy syndrome	0.000203	0.00353	CcSEcCtD
Pyrimethamine—Vomiting—Trimethadione—epilepsy syndrome	0.000202	0.0035	CcSEcCtD
Pyrimethamine—Leukopenia—Felbamate—epilepsy syndrome	0.000198	0.00343	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Levetiracetam—epilepsy syndrome	0.000197	0.00342	CcSEcCtD
Pyrimethamine—Decreased appetite—Acetazolamide—epilepsy syndrome	0.000195	0.00338	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Fosphenytoin—epilepsy syndrome	0.000194	0.00337	CcSEcCtD
Pyrimethamine—Leukopenia—Zonisamide—epilepsy syndrome	0.000193	0.00336	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Valproic Acid—epilepsy syndrome	0.000192	0.00334	CcSEcCtD
Pyrimethamine—Anorexia—Levetiracetam—epilepsy syndrome	0.000192	0.00333	CcSEcCtD
Pyrimethamine—Hypersensitivity—Lacosamide—epilepsy syndrome	0.000191	0.00331	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Fosphenytoin—epilepsy syndrome	0.00019	0.0033	CcSEcCtD
Pyrimethamine—Pancytopenia—Pregabalin—epilepsy syndrome	0.000187	0.00325	CcSEcCtD
Pyrimethamine—Leukopenia—Clonazepam—epilepsy syndrome	0.000186	0.00324	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Diazepam—epilepsy syndrome	0.000186	0.00323	CcSEcCtD
Pyrimethamine—Leukopenia—Phenytoin—epilepsy syndrome	0.000185	0.00322	CcSEcCtD
Pyrimethamine—Anorexia—Fosphenytoin—epilepsy syndrome	0.000185	0.00321	CcSEcCtD
Pyrimethamine—Leukopenia—Oxcarbazepine—epilepsy syndrome	0.000184	0.0032	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Diazepam—epilepsy syndrome	0.000182	0.00317	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Felbamate—epilepsy syndrome	0.00018	0.00313	CcSEcCtD
Pyrimethamine—Vomiting—Phenobarbital—epilepsy syndrome	0.000179	0.0031	CcSEcCtD
Pyrimethamine—Anorexia—Diazepam—epilepsy syndrome	0.000177	0.00308	CcSEcCtD
Pyrimethamine—Leukopenia—Carbamazepine—epilepsy syndrome	0.000177	0.00307	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Felbamate—epilepsy syndrome	0.000176	0.00306	CcSEcCtD
Pyrimethamine—Vomiting—Rufinamide—epilepsy syndrome	0.000175	0.00304	CcSEcCtD
Pyrimethamine—Decreased appetite—Levetiracetam—epilepsy syndrome	0.000175	0.00303	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Pregabalin—epilepsy syndrome	0.000174	0.00302	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Zonisamide—epilepsy syndrome	0.000173	0.003	CcSEcCtD
Pyrimethamine—Anorexia—Felbamate—epilepsy syndrome	0.000172	0.00298	CcSEcCtD
Pyrimethamine—Leukopenia—Lamotrigine—epilepsy syndrome	0.000171	0.00297	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.00017	0.00295	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.000169	0.00293	CcSEcCtD
Pyrimethamine—Decreased appetite—Fosphenytoin—epilepsy syndrome	0.000169	0.00293	CcSEcCtD
Pyrimethamine—Anorexia—Zonisamide—epilepsy syndrome	0.000168	0.00292	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.000168	0.00292	CcSEcCtD
Pyrimethamine—Haematuria—Pregabalin—epilepsy syndrome	0.000167	0.00291	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Clonazepam—epilepsy syndrome	0.000166	0.00289	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Phenytoin—epilepsy syndrome	0.000165	0.00287	CcSEcCtD
Pyrimethamine—Erythema multiforme—Valproic Acid—epilepsy syndrome	0.000165	0.00286	CcSEcCtD
Pyrimethamine—Vomiting—Lacosamide—epilepsy syndrome	0.000165	0.00286	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Oxcarbazepine—epilepsy syndrome	0.000164	0.00286	CcSEcCtD
Pyrimethamine—Decreased appetite—Vigabatrin—epilepsy syndrome	0.000164	0.00285	CcSEcCtD
Pyrimethamine—Anorexia—Clonazepam—epilepsy syndrome	0.000162	0.00281	CcSEcCtD
Pyrimethamine—Decreased appetite—Diazepam—epilepsy syndrome	0.000162	0.00281	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000161	0.0028	CcSEcCtD
Pyrimethamine—Anorexia—Phenytoin—epilepsy syndrome	0.000161	0.00279	CcSEcCtD
Pyrimethamine—Anorexia—Oxcarbazepine—epilepsy syndrome	0.00016	0.00278	CcSEcCtD
Pyrimethamine—Vomiting—Clobazam—epilepsy syndrome	0.00016	0.00277	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Gabapentin—epilepsy syndrome	0.000159	0.00277	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Topiramate—epilepsy syndrome	0.000158	0.00275	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Carbamazepine—epilepsy syndrome	0.000158	0.00274	CcSEcCtD
Pyrimethamine—Decreased appetite—Felbamate—epilepsy syndrome	0.000157	0.00272	CcSEcCtD
Pyrimethamine—Anorexia—Carbamazepine—epilepsy syndrome	0.000154	0.00267	CcSEcCtD
Pyrimethamine—Haematuria—Gabapentin—epilepsy syndrome	0.000153	0.00266	CcSEcCtD
Pyrimethamine—Decreased appetite—Zonisamide—epilepsy syndrome	0.000153	0.00266	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Lamotrigine—epilepsy syndrome	0.000152	0.00265	CcSEcCtD
Pyrimethamine—Hypersensitivity—Midazolam—epilepsy syndrome	0.00015	0.0026	CcSEcCtD
Pyrimethamine—Erythema multiforme—Pregabalin—epilepsy syndrome	0.000149	0.00259	CcSEcCtD
Pyrimethamine—Anorexia—Lamotrigine—epilepsy syndrome	0.000148	0.00258	CcSEcCtD
Pyrimethamine—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000148	0.00257	CcSEcCtD
Pyrimethamine—Decreased appetite—Clonazepam—epilepsy syndrome	0.000148	0.00257	CcSEcCtD
Pyrimethamine—Decreased appetite—Phenytoin—epilepsy syndrome	0.000147	0.00255	CcSEcCtD
Pyrimethamine—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.000146	0.00254	CcSEcCtD
Pyrimethamine—Pancytopenia—Topiramate—epilepsy syndrome	0.000144	0.0025	CcSEcCtD
Pyrimethamine—Vomiting—Acetazolamide—epilepsy syndrome	0.000142	0.00247	CcSEcCtD
Pyrimethamine—Decreased appetite—Carbamazepine—epilepsy syndrome	0.00014	0.00243	CcSEcCtD
Pyrimethamine—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000139	0.00242	CcSEcCtD
Pyrimethamine—Hypersensitivity—Diazepam—epilepsy syndrome	0.000137	0.00238	CcSEcCtD
Pyrimethamine—Erythema multiforme—Gabapentin—epilepsy syndrome	0.000137	0.00237	CcSEcCtD
Pyrimethamine—Leukopenia—Valproic Acid—epilepsy syndrome	0.000136	0.00236	CcSEcCtD
Pyrimethamine—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000135	0.00235	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	0.000134	0.00233	CcSEcCtD
Pyrimethamine—Vomiting—Propofol—epilepsy syndrome	0.000132	0.0023	CcSEcCtD
Pyrimethamine—Hypersensitivity—Zonisamide—epilepsy syndrome	0.00013	0.00226	CcSEcCtD
Pyrimethamine—Vomiting—Midazolam—epilepsy syndrome	0.000129	0.00225	CcSEcCtD
Pyrimethamine—Haematuria—Topiramate—epilepsy syndrome	0.000129	0.00224	CcSEcCtD
Pyrimethamine—Vomiting—Levetiracetam—epilepsy syndrome	0.000128	0.00222	CcSEcCtD
Pyrimethamine—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000125	0.00217	CcSEcCtD
Pyrimethamine—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000124	0.00216	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000124	0.00215	CcSEcCtD
Pyrimethamine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000124	0.00215	CcSEcCtD
Pyrimethamine—Vomiting—Fosphenytoin—epilepsy syndrome	0.000123	0.00214	CcSEcCtD
Pyrimethamine—Leukopenia—Pregabalin—epilepsy syndrome	0.000123	0.00213	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000121	0.0021	CcSEcCtD
Pyrimethamine—Vomiting—Vigabatrin—epilepsy syndrome	0.00012	0.00209	CcSEcCtD
Pyrimethamine—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000119	0.00206	CcSEcCtD
Pyrimethamine—Vomiting—Diazepam—epilepsy syndrome	0.000118	0.00206	CcSEcCtD
Pyrimethamine—Anorexia—Valproic Acid—epilepsy syndrome	0.000118	0.00205	CcSEcCtD
Pyrimethamine—Erythema multiforme—Topiramate—epilepsy syndrome	0.000115	0.002	CcSEcCtD
Pyrimethamine—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000115	0.00199	CcSEcCtD
Pyrimethamine—Vomiting—Felbamate—epilepsy syndrome	0.000115	0.00199	CcSEcCtD
Pyrimethamine—Leukopenia—Gabapentin—epilepsy syndrome	0.000112	0.00195	CcSEcCtD
Pyrimethamine—Vomiting—Zonisamide—epilepsy syndrome	0.000112	0.00195	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000112	0.00194	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.00011	0.0019	CcSEcCtD
Pyrimethamine—Vomiting—Clonazepam—epilepsy syndrome	0.000108	0.00188	CcSEcCtD
Pyrimethamine—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000108	0.00187	CcSEcCtD
Pyrimethamine—Vomiting—Phenytoin—epilepsy syndrome	0.000107	0.00186	CcSEcCtD
Pyrimethamine—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000107	0.00185	CcSEcCtD
Pyrimethamine—Anorexia—Pregabalin—epilepsy syndrome	0.000107	0.00185	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000103	0.00178	CcSEcCtD
Pyrimethamine—Vomiting—Carbamazepine—epilepsy syndrome	0.000102	0.00178	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.0001	0.00174	CcSEcCtD
Pyrimethamine—Vomiting—Lamotrigine—epilepsy syndrome	9.9e-05	0.00172	CcSEcCtD
Pyrimethamine—Anorexia—Gabapentin—epilepsy syndrome	9.78e-05	0.0017	CcSEcCtD
Pyrimethamine—Decreased appetite—Pregabalin—epilepsy syndrome	9.72e-05	0.00169	CcSEcCtD
Pyrimethamine—Leukopenia—Topiramate—epilepsy syndrome	9.46e-05	0.00164	CcSEcCtD
Pyrimethamine—Hypersensitivity—Valproic Acid—epilepsy syndrome	9.12e-05	0.00158	CcSEcCtD
Pyrimethamine—Decreased appetite—Gabapentin—epilepsy syndrome	8.92e-05	0.00155	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Topiramate—epilepsy syndrome	8.45e-05	0.00147	CcSEcCtD
Pyrimethamine—Hypersensitivity—Pregabalin—epilepsy syndrome	8.24e-05	0.00143	CcSEcCtD
Pyrimethamine—Anorexia—Topiramate—epilepsy syndrome	8.23e-05	0.00143	CcSEcCtD
Pyrimethamine—Vomiting—Valproic Acid—epilepsy syndrome	7.87e-05	0.00137	CcSEcCtD
Pyrimethamine—Hypersensitivity—Gabapentin—epilepsy syndrome	7.56e-05	0.00131	CcSEcCtD
Pyrimethamine—Decreased appetite—Topiramate—epilepsy syndrome	7.5e-05	0.0013	CcSEcCtD
Pyrimethamine—Vomiting—Pregabalin—epilepsy syndrome	7.11e-05	0.00124	CcSEcCtD
Pyrimethamine—Lamotrigine—ABCB1—epilepsy syndrome	6.83e-05	0.0204	CrCbGaD
Pyrimethamine—Vomiting—Gabapentin—epilepsy syndrome	6.52e-05	0.00113	CcSEcCtD
Pyrimethamine—Hypersensitivity—Topiramate—epilepsy syndrome	6.36e-05	0.0011	CcSEcCtD
Pyrimethamine—Vomiting—Topiramate—epilepsy syndrome	5.49e-05	0.000953	CcSEcCtD
Pyrimethamine—DHFR—Disease—PPIA—epilepsy syndrome	1.67e-05	0.000975	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.66e-05	0.00097	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	1.65e-05	0.000968	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	1.62e-05	0.000951	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CHRM3—epilepsy syndrome	1.6e-05	0.000939	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—KCNJ11—epilepsy syndrome	1.6e-05	0.000939	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—PRKCB—epilepsy syndrome	1.6e-05	0.000937	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CA13—epilepsy syndrome	1.57e-05	0.000922	CbGpPWpGaD
Pyrimethamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.56e-05	0.000915	CbGpPWpGaD
Pyrimethamine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.55e-05	0.000907	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	1.51e-05	0.000885	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—ATM—epilepsy syndrome	1.46e-05	0.000855	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	1.46e-05	0.000852	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—PRKCB—epilepsy syndrome	1.43e-05	0.000837	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	1.32e-05	0.000774	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ABCG2—epilepsy syndrome	1.31e-05	0.000765	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CA13—epilepsy syndrome	1.29e-05	0.000757	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CA13—epilepsy syndrome	1.28e-05	0.00075	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CYP2C19—epilepsy syndrome	1.27e-05	0.000746	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.27e-05	0.000742	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CYP11A1—epilepsy syndrome	1.27e-05	0.000741	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SLC2A1—epilepsy syndrome	1.23e-05	0.000722	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—JUNB—epilepsy syndrome	1.22e-05	0.000717	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—NOS1—epilepsy syndrome	1.22e-05	0.000712	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—FAR1—epilepsy syndrome	1.19e-05	0.000699	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—L2HGDH—epilepsy syndrome	1.19e-05	0.000699	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ADK—epilepsy syndrome	1.19e-05	0.000699	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GLUD1—epilepsy syndrome	1.19e-05	0.000699	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CERS1—epilepsy syndrome	1.19e-05	0.000699	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PDXK—epilepsy syndrome	1.19e-05	0.000699	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—HBEGF—epilepsy syndrome	1.16e-05	0.000679	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CYP2D6—epilepsy syndrome	1.14e-05	0.000669	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—AKT3—epilepsy syndrome	1.14e-05	0.000667	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—ADAM10—epilepsy syndrome	1.11e-05	0.000651	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GAMT—epilepsy syndrome	1.09e-05	0.000639	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NHLRC1—epilepsy syndrome	1.09e-05	0.000639	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PNPO—epilepsy syndrome	1.09e-05	0.000639	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—EPM2A—epilepsy syndrome	1.09e-05	0.000639	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ADRA2A—epilepsy syndrome	1.09e-05	0.000637	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—BCHE—epilepsy syndrome	1.08e-05	0.000634	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CDC42—epilepsy syndrome	1.04e-05	0.000608	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—SLC2A1—epilepsy syndrome	1.03e-05	0.000605	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.03e-05	0.000604	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PLCB1—epilepsy syndrome	1.02e-05	0.000598	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—TH—epilepsy syndrome	1.02e-05	0.000596	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—QDPR—epilepsy syndrome	1.01e-05	0.000594	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CA4—epilepsy syndrome	1.01e-05	0.000594	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—POMC—epilepsy syndrome	1.01e-05	0.000592	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ADK—epilepsy syndrome	9.8e-06	0.000574	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PDXK—epilepsy syndrome	9.8e-06	0.000574	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CERS1—epilepsy syndrome	9.8e-06	0.000574	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—L2HGDH—epilepsy syndrome	9.8e-06	0.000574	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—FAR1—epilepsy syndrome	9.8e-06	0.000574	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GLUD1—epilepsy syndrome	9.8e-06	0.000574	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—FAR1—epilepsy syndrome	9.71e-06	0.000569	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	9.71e-06	0.000569	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ADK—epilepsy syndrome	9.71e-06	0.000569	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	9.71e-06	0.000569	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CERS1—epilepsy syndrome	9.71e-06	0.000569	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PDXK—epilepsy syndrome	9.71e-06	0.000569	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—COX3—epilepsy syndrome	9.54e-06	0.000559	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—HES1—epilepsy syndrome	9.51e-06	0.000557	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—FYN—epilepsy syndrome	9.25e-06	0.000541	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—H2AFX—epilepsy syndrome	9.22e-06	0.00054	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLCO1A2—epilepsy syndrome	9.05e-06	0.00053	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—KCNB1—epilepsy syndrome	9.05e-06	0.00053	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PFKL—epilepsy syndrome	9.05e-06	0.00053	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CACNA2D2—epilepsy syndrome	9.05e-06	0.00053	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLC6A8—epilepsy syndrome	9.05e-06	0.00053	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—EPM2A—epilepsy syndrome	8.96e-06	0.000525	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NHLRC1—epilepsy syndrome	8.96e-06	0.000525	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PNPO—epilepsy syndrome	8.96e-06	0.000525	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GAMT—epilepsy syndrome	8.96e-06	0.000525	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—YWHAZ—epilepsy syndrome	8.89e-06	0.000521	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PNPO—epilepsy syndrome	8.88e-06	0.00052	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	8.88e-06	0.00052	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GAMT—epilepsy syndrome	8.88e-06	0.00052	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	8.88e-06	0.00052	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	8.84e-06	0.000518	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	8.79e-06	0.000514	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CCR5—epilepsy syndrome	8.55e-06	0.000501	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—HMOX1—epilepsy syndrome	8.5e-06	0.000498	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CAT—epilepsy syndrome	8.39e-06	0.000491	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CA4—epilepsy syndrome	8.33e-06	0.000488	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—QDPR—epilepsy syndrome	8.33e-06	0.000488	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—POMC—epilepsy syndrome	8.31e-06	0.000486	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ATIC—epilepsy syndrome	8.27e-06	0.000484	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NEU1—epilepsy syndrome	8.27e-06	0.000484	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—UPB1—epilepsy syndrome	8.27e-06	0.000484	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CA4—epilepsy syndrome	8.26e-06	0.000484	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—QDPR—epilepsy syndrome	8.26e-06	0.000484	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	8.23e-06	0.000482	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ABCB1—epilepsy syndrome	8.16e-06	0.000478	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HSD17B4—epilepsy syndrome	7.96e-06	0.000466	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TSC2—epilepsy syndrome	7.95e-06	0.000465	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—COX3—epilepsy syndrome	7.83e-06	0.000459	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—APOE—epilepsy syndrome	7.78e-06	0.000456	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—COX3—epilepsy syndrome	7.77e-06	0.000455	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PPP1R3C—epilepsy syndrome	7.69e-06	0.00045	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GBE1—epilepsy syndrome	7.69e-06	0.00045	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GPX1—epilepsy syndrome	7.59e-06	0.000444	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	7.52e-06	0.00044	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—KCNB1—epilepsy syndrome	7.43e-06	0.000435	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLCO1A2—epilepsy syndrome	7.43e-06	0.000435	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	7.43e-06	0.000435	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PFKL—epilepsy syndrome	7.43e-06	0.000435	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CACNA2D2—epilepsy syndrome	7.43e-06	0.000435	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	7.36e-06	0.000431	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	7.36e-06	0.000431	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PFKL—epilepsy syndrome	7.36e-06	0.000431	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	7.36e-06	0.000431	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	7.36e-06	0.000431	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—IL6ST—epilepsy syndrome	7.31e-06	0.000428	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—NOS2—epilepsy syndrome	7.25e-06	0.000424	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ASAH1—epilepsy syndrome	7.23e-06	0.000423	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	7.2e-06	0.000421	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	7.15e-06	0.000419	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—STXBP1—epilepsy syndrome	7.03e-06	0.000412	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NT5E—epilepsy syndrome	6.86e-06	0.000401	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALAD—epilepsy syndrome	6.86e-06	0.000401	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NEU1—epilepsy syndrome	6.79e-06	0.000398	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—UPB1—epilepsy syndrome	6.79e-06	0.000398	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ATIC—epilepsy syndrome	6.79e-06	0.000398	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NEU1—epilepsy syndrome	6.73e-06	0.000394	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—UPB1—epilepsy syndrome	6.73e-06	0.000394	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ATIC—epilepsy syndrome	6.73e-06	0.000394	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—AGT—epilepsy syndrome	6.65e-06	0.000389	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CACNA1A—epilepsy syndrome	6.54e-06	0.000383	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALDH7A1—epilepsy syndrome	6.54e-06	0.000383	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	6.54e-06	0.000383	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—APOE—epilepsy syndrome	6.52e-06	0.000382	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	6.48e-06	0.000379	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ST3GAL3—epilepsy syndrome	6.4e-06	0.000375	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GBE1—epilepsy syndrome	6.31e-06	0.00037	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	6.31e-06	0.00037	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ADSL—epilepsy syndrome	6.27e-06	0.000367	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GBE1—epilepsy syndrome	6.26e-06	0.000366	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	6.26e-06	0.000366	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GLUL—epilepsy syndrome	6.15e-06	0.00036	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	6.12e-06	0.000358	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CACNA1D—epilepsy syndrome	6.04e-06	0.000353	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	5.94e-06	0.000348	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—FGF2—epilepsy syndrome	5.91e-06	0.000346	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	5.89e-06	0.000345	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	5.78e-06	0.000338	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	5.73e-06	0.000335	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—TXNRD1—epilepsy syndrome	5.65e-06	0.00033	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NT5E—epilepsy syndrome	5.63e-06	0.000329	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALAD—epilepsy syndrome	5.63e-06	0.000329	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—POMC—epilepsy syndrome	5.6e-06	0.000328	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NT5E—epilepsy syndrome	5.58e-06	0.000327	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALAD—epilepsy syndrome	5.58e-06	0.000327	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—AQP1—epilepsy syndrome	5.48e-06	0.000321	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MTOR—epilepsy syndrome	5.38e-06	0.000315	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	5.37e-06	0.000314	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	5.37e-06	0.000314	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PTGS2—epilepsy syndrome	5.33e-06	0.000312	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	5.32e-06	0.000312	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	5.32e-06	0.000312	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.26e-06	0.000308	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	5.25e-06	0.000308	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	5.21e-06	0.000305	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ADSL—epilepsy syndrome	5.15e-06	0.000301	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ALB—epilepsy syndrome	5.1e-06	0.000299	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ADSL—epilepsy syndrome	5.1e-06	0.000299	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GLUL—epilepsy syndrome	5.05e-06	0.000296	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GLUL—epilepsy syndrome	5e-06	0.000293	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	4.96e-06	0.00029	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	4.96e-06	0.00029	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	4.95e-06	0.00029	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	4.91e-06	0.000288	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	4.63e-06	0.000271	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.62e-06	0.00027	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	4.59e-06	0.000269	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.52e-06	0.000265	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—AQP1—epilepsy syndrome	4.5e-06	0.000263	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PTGS2—epilepsy syndrome	4.47e-06	0.000261	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—AQP1—epilepsy syndrome	4.46e-06	0.000261	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SRC—epilepsy syndrome	4.31e-06	0.000252	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.28e-06	0.000251	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	4.07e-06	0.000238	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	4.07e-06	0.000238	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	4.04e-06	0.000237	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	4.03e-06	0.000236	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	4.03e-06	0.000236	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	3.94e-06	0.00023	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	3.91e-06	0.000229	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.88e-06	0.000227	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.76e-06	0.00022	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.68e-06	0.000215	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.54e-06	0.000207	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	3.53e-06	0.000207	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	3.36e-06	0.000197	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—BCHE—epilepsy syndrome	3.35e-06	0.000196	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	3.32e-06	0.000194	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	3.29e-06	0.000192	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	3.23e-06	0.000189	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	3.21e-06	0.000188	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	3.2e-06	0.000188	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	3.19e-06	0.000187	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	3.18e-06	0.000186	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.16e-06	0.000185	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	3.16e-06	0.000185	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—TH—epilepsy syndrome	3.15e-06	0.000184	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.1e-06	0.000181	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.88e-06	0.000169	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.87e-06	0.000168	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	2.76e-06	0.000162	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.75e-06	0.000161	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.74e-06	0.00016	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.72e-06	0.00016	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—AKT1—epilepsy syndrome	2.68e-06	0.000157	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	2.63e-06	0.000154	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.62e-06	0.000153	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	2.6e-06	0.000152	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.59e-06	0.000152	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CAT—epilepsy syndrome	2.59e-06	0.000152	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—TH—epilepsy syndrome	2.58e-06	0.000151	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	2.57e-06	0.000151	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—TH—epilepsy syndrome	2.56e-06	0.00015	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.52e-06	0.000148	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	2.52e-06	0.000148	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GPX1—epilepsy syndrome	2.34e-06	0.000137	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—AKT1—epilepsy syndrome	2.24e-06	0.000131	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.16e-06	0.000126	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.14e-06	0.000125	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.13e-06	0.000125	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.11e-06	0.000123	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.07e-06	0.000121	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—AGT—epilepsy syndrome	2.06e-06	0.00012	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.05e-06	0.00012	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APOE—epilepsy syndrome	2.01e-06	0.000118	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.92e-06	0.000113	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.91e-06	0.000112	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.73e-06	0.000101	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.69e-06	9.88e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.67e-06	9.79e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.65e-06	9.68e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.64e-06	9.6e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.58e-06	9.23e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.42e-06	8.31e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.41e-06	8.24e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.38e-06	8.08e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.29e-06	7.58e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.28e-06	7.52e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.13e-06	6.63e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.12e-06	6.57e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—AKT1—epilepsy syndrome	6.94e-07	4.06e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	5.69e-07	3.33e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—AKT1—epilepsy syndrome	5.64e-07	3.3e-05	CbGpPWpGaD
